GRP78 and α2-macroglobulin are new promising targets for metastatic castrate-resistant prostate cancer treatment
Crossref DOI link: https://doi.org/10.1007/s12094-015-1324-9
Published Online: 2015-07-02
Published Print: 2015-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Vlachostergios, P. J.
Balmiki, R. L.
Daya, R.
Text and Data Mining valid from 2015-07-02
